Data Insights

ASX 200 stocks hitting fresh 52-week highs and lows – Week 22

Mon 03 Jun 24, 10:29am (AEST)
marketsasx
Source: Shutterstock

Stocks in article

pme
MktCap:
-
tlx
MktCap:
-
fph
MktCap:
-
a2m
MktCap:
-
bga
MktCap:
-
lov
MktCap:
-
hub
MktCap:
-
pni
MktCap:
-
qub
MktCap:
-
csr
MktCap:
-
awc
MktCap:
-
hmc
MktCap:
-
tah
MktCap:
-
ctd
MktCap:
-
dmp
MktCap:
-
stx
MktCap:
-
ora
MktCap:
-
sgm
MktCap:
-
nec
MktCap:
-
spk
MktCap:
-

Share article

Key Points

  • The biotech sector has been heating up all year and large cap names like Telix Pharmaceuticals are leading the charge
  • Dairy-related stocks like Bega Cheese and A2 Milk are trading at 52-week highs as earnings results and industry data suggest an improvement in business conditions

Welcome back to the 52-week Series – A recap of ASX 200 stocks that have tagged a fresh yearly highs and lows in the past week.


52-Week Highs and Lows by Sector

  • Healthcare: 3 Highs, 1 Low

  • Materials: 2 Highs, 3 Lows

  • Financials: 2 Highs, 0 Lows

  • Staples: 2 Highs, 0 Lows

  • Discretionary: 1 High, 3 Lows

  • Industrials: 1 High, 1 Low

  • Utilities: 1 High, 0 Lows

  • Real Estate: 1 High, 0 Lows

  • Telecommunication: 0 Highs, 2 Lows

  • Energy: 0 Highs, 1 Low

  • Technology: 0 Highs, 0 Lows


Why do 52-Week Highs and Lows Matter

Here are some of the key points our first 52-Week article:

  • A research thesis by Thomas J. George and Chuan-Yang Hwang titled The 52-Week High and Momentum Investing concludes that stocks nearing their 52-week high tend to outperform in the future, surpassing the predictive power of past returns.

  • US trader Mark Minervini also notes that “when you see a growing number of names in a particular industry making new 52-week highs (especially coming off a market low), this could be an indication that a group advance is underway.”

  • 1851 Capital Chief Investment Officer Chris Stott says the numbers are useful in helping to determine which stocks have the momentum to keep making fresh highs. The data is used to identify continuous winners and generate fresh ideas.


Healthcare stocks at 52-week highs

The biotech sector is running hot this year and a few names outside of the large cap space to think about include: Dimerix (ASX: DXB), Clarity Pharma (ASX: CU6), Botanix (ASX: BOT) and LTR Pharma (ASX: LTP).

Ticker

Company

Close

1 Week

1 Year

PME

Pro Medicus

$120.12

3.8%

93.3%

TLX

Telix Pharmaceuticals

$18.15

17.3%

67.7%

FPH

Fisher & Paykel

$27.20

4.9%

22.5%

Data shows any stock to have hit a 52-week high in the past week. Share price and performance as at Friday, 31 May close

Staples at 52-week highs

It's interesting to see two dairy-related names rally to fresh yearly highs. Here are some of the recent catalysts:

  • Bega Cheese was one of the best performing stocks during February reporting season, up 13% on the day (22 Feb) and another 9% over the next three sessions. The result highlighted improving profitability amid rising commodity prices and growing milk volumes as well as recent benefits from restructuring efforts

  • Citi analysts observed a number of data points about NZ port data, including:

    • China label: NZ infant milk formula exports from Jan-Apr 2024 to China down 11% year-on-year, cycling elevated numbers from last year. Volumes are still up more than three times the equivalent period in 2022

    • English label (China): Growth in volumes to Hong Kong has accelerated year-to-date (Jan-Apr 2024), up 145% year-on-year

    • English label (Australia): Growth in export volumes to Australia have accelerated year-to-date (Jan-Apr 2024), up 74% year-on-year following a 51% decline in the first half of FY24

  • Bega Cheese received a double upgrade from Underperform to Outperform by CLSA on Friday, 31 May. The analysts raised their target price from $4.0 to $4.65

Ticker

Company

Close

1 Week

1 Year

A2M

A2 Milk

$7.08

-0.6%

33.6%

BGA

Bega Cheese

$4.46

3.5%

23.9%

Data shows any stock to have hit a 52-week high in the past week. Share price and performance as at Friday, 31 May close

ASX 200 stocks at 52-week highs

Ticker

Company

Close

Sector

1 Week

1 Year

LOV

Lovisa

$33.91

Discretionary

5.7%

72.8%

HUB

Hub24

$42.79

Financials

0.2%

72.5%

PNI

Pinnacle Investment Management

$13.18

Financials

1.0%

50.6%

QUB

Qube Holdings

$3.59

Industrials

-1.4%

23.8%

CSR

CSR

$8.90

Materials

-0.3%

80.9%

AWC

Alumina

$1.90

Materials

8.9%

33.9%

HMC

HMC Capital

$7.20

Real Estate

4.1%

66.7%

ORG

Origin Energy

$10.19

Utilities

-1.6%

21.7%

Data shows any stock to have hit a 52-week high in the past week. Share price and performance as at Friday, 31 May close

ASX 200 stocks at 52-week lows

This week's 52-week low list reflects a broad range of underperformers, including those affected by management controversy (TAH), weaker-than-expected earnings (KLS, ORA, SGM) and sector headwinds (e.g. RHC and hospital providers face continued cost pressures and volume uncertainties).

Ticker

Company

Close

Sector

1 Week

1 Year

TAH

Tabcorp

$0.62

Discretionary

-1.60%

-46.52%

CTD

Corporate Travel Management

$13.30

Discretionary

-4.11%

-36.18%

DMP

Domino's Pizza

$38.71

Discretionary

5.05%

-19.24%

STX

Strike Energy

$0.20

Energy

-6.98%

-59.18%

RHC

Ramsay Health Care

$47.11

Health Care

-3.21%

-18.57%

KLS

Kelsian Group

$5.18

Industrials

-1.33%

-24.16%

ORA

Orora

$2.05

Materials

-4.21%

-32.49%

SGM

Sims

$10.61

Materials

-4.84%

-28.02%

CRN

Coronado Global

$1.12

Materials

-2.19%

-16.17%

NEC

Nine Entertainment

$1.41

Telecommunication

-4.75%

-27.58%

SPK

Spark New Zealand

$3.80

Telecommunication

-0.26%

-20.34%

Data shows any stock to have hit a 52-week low in the past week. Share price and performance as at Friday, 31 May close

 

Written By

Kerry Sun

Content Strategist

Kerry holds a Bachelor of Commerce from Monash University. He is an avid swing trader, focused on technical set ups and breakouts. Outside of writing and trading, Kerry is a big UFC fan, loves poker and training Muay Thai. Connect via LinkedIn or email.

Get the latest news and insights direct to your inbox

Subscribe free